Explore the words cloud of the ORIGIN project. It provides you a very rough idea of what is the project "ORIGIN" about.
The following table provides information about the project.
UNIVERSITY OF LIMERICK
|Coordinator Country||Ireland [IE]|
|Total cost||4˙819˙920 €|
|EC max contribution||4˙819˙920 € (100%)|
1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
|Duration (year-month-day)||from 2020-01-01 to 2022-12-31|
Take a look of project's partnership.
|1||UNIVERSITY OF LIMERICK||IE (LIMERICK)||coordinator||913˙380.00|
|2||VRIJE UNIVERSITEIT BRUSSEL||BE (BRUSSEL)||participant||741˙528.00|
|4||THE QUEEN'S UNIVERSITY OF BELFAST||UK (BELFAST)||participant||688˙342.00|
|5||ECKERT & ZIEGLER BEBIG GMBH||DE (BERLIN)||participant||590˙812.00|
|6||UNIVERSITA DEGLI STUDI DELL'INSUBRIA||IT (VARESE)||participant||462˙150.00|
|7||GALWAY CLINIC DOUGHISKA LIMITED||IE (GALWAY)||participant||372˙456.00|
|8||CENTRE ANTOINE LACASSAGNE||FR (NICE CEDEX)||participant||346˙000.00|
ORIGIN aims to deliver more effective, photonics-enabled, brachytherapy for cancer treatment through advanced real-time radiation dose imaging and source localisation. This will be achieved by the development of a new optical fibre based sensor system to support diagnostics-driven therapy through enhanced adaptive brachytherapy. A 16-point optical fibre sensors system will be developed, for Low Dose Rate (LDR) and High Dose Rate (HDR) Brachytherapy, with sensitivity of 150 counts/Gy for LDR- and 2500 counts/mGy for HDR- BT alongside a dedicated data acquisition system providing a dose mapping system with a spatial resolution of 0.5mm (HDR) and 3mm (LDR) and time resolution of 0.1s (HDR) and 0.5s (LDR), with 5% uncertainty. This is a 50% improvement in uncertainty over existing systems. Further interrogation of the optical signal will provide real-time monitoring of the radiation source location during treatment. The ORIGIN system will be integrated into existing clinical brachytherapy treatment planning and delivery systems to confirm that the dose prescribed to the tumour is achieved, whilst ensuring the dose to organs at risk (OARs) is within acceptable limits. This will provide for optimised dose-led, patient-oriented, personalised treatment plans leading to improved patient outcomes and prevention of treatment errors, with the potential to reduce the overall risk of treatment error by 55%. The optical fibre radiation dosimeters will be further optimised for improved optical signal collection efficiency, higher signal-to-noise ratio (SNR) and repeatable high volume fabrication. Taking manufacturability into consideration from the outset will ensure that ORIGIN establishes Europe at the fore of brachytherapy system development and photonics manufacturing.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ORIGIN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ORIGIN" are provided by the European Opendata Portal: CORDIS opendata.
Incubating High-IMPACT New Generation EdTech Disruptors for Inclusive & Personalised LearningRead More
European Conferences on Networks and Communications (EuCNC)Read More
A Single Digital Market for Industrial Geospatial Data AssetsRead More